Uploaded January 2024 | Updated November 2026, 13 hours ago
Roberta Pesce presentó programas educativos y de apoyo de SRNA, incluyendo la expansión de la organización a lo largo de los años, la creación de redes de apoyo, el desarrollo de recursos en línea, y la promoción de la investigación científica, con el objetivo de mejorar la calidad de vida de las personas con trastornos neuroinmunes poco frecuentes.
Trastornos Neuroinmunológicos Poco Frecuentes Simposio en Español 2023
Roberta Pesce of Siegel Rare Neuroimmune Association (SRNA)
Roberta Pesce presentó programas educativos y de apoyo de SRNA, incluyendo la expansión de la organización a lo largo de los años, la creación de redes de apoyo, el desarrollo de recursos en línea, y la promoción de la investigación científica, con el objetivo de mejorar la calidad de vida de las personas con trastornos neuroinmunes poco frecuentes.
Trastornos Neuroinmunológicos Poco Frecuentes Simposio en Español 2023
Roberta Pesce of Siegel Rare Neuroimmune Association (SRNA)
![1312. Parenting is Hard | Part 6
In part six of the “Ask the Expert, Research Edition” mini-series, “Parenting is Hard,” Krissy Dilger of SRNA was joined by Barbara Babcock, a family therapist from the UKs National Health Service, to discuss the role of siblings in families with a child diagnosed with a rare neuroimmune disorder. Barbara shared findings from her research on how siblings provide crucial support to parents and the positive impacts this has on family dynamics [00:04:31]. They explored the concept of parentification and the importance of assigning age-appropriate tasks to siblings [00:25:10]. Barbara also provided advice on fostering healthy sibling relationships and the significance of open communication [00:35:34].
At the end of this mini-series, we will host a Q&A episode where Barbara will answer questions from the community. To submit your question, please visit https://srna.ngo/submit
Barbara Babcock works as a Family Therapist in a child and adolescent mental health outpatient unit in the United Kingdoms National Health Service. In her private practice, she works with individuals and couples who are navigating challenging health issues and wish to get their lives back. She obtained her Master of Science in Family Therapy from the Institute of Psychiatry, Psychology, and Neuroscience at Kings College London. Barbara also has a Master of Arts in Coaching Psychology/Psychological Coaching and her dissertation research focused on the impact that a systemic approach to coaching has on the wellbeing of adults who have a rare neuroimmune disorder and their primary caregivers. Previously, she was Chair of the Transverse Myelitis Society, from 2013 to 2016, and led their Family Weekend from 2015 to 2019, an event to support families who have a child/adolescent with a rare neuroimmune disorder to discover their potential through challenging outdoor activities. She had transverse myelitis in 2008 and is originally from Pennsylvania, USA. You can contact her at barbara@returntowellness.co.uk and her website is www.returntowellness.co.uk
00:00 Introduction
00:28 Meet Barbara Babcock
02:08 Theme Four: Support from Siblings
04:31 Siblings Characteristics and Their Impact
06:57 Voluntary Help from Siblings
25:10 Parentification: Understanding the Concept
36:34 Fostering Healthy Sibling Relationships
39:20 Conclusion and Final Thoughts 1312. Parenting is Hard | Part 6](https://i.ytimg.com/vi/Ixzhe0MXZTQ/mqdefault.jpg)

![2026 RNDS | Pediatric Case Series in Anti-Aquaporin-4 Antibody-Positive NMOSD
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Darina Dinov, DO, of Penn State University, spoke about pediatric neuromyelitis optica spectrum disorder (NMOSD) and how children have tolerated the treatment inebilizumab [00:00:05]. She compared pediatric and adult NMOSD, including the lack of FDA-approved medications for children and what off-label use can mean for insurance approval [00:01:40]. She explained the role of aquaporin-4 and B cells, and how inebilizumab reaches more of the cells that lead to antibody production than rituximab does [00:05:20]. Dr. Dinov presented a retrospective case series of four children, ages seven to 17, treated at UT Southwestern and Childrens Dallas, all of whom tolerated their infusions [00:10:54]. She closed with what the findings may mean for families and clinicians seeking insurance approval, and the two ongoing pediatric trials [00:18:25].
Darina Dinov, DO, is a neurologist at Penn State University specializing in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and the blood vessels that relate to these structures. She is passionate about advancing our understanding through research, education, and innovation, and her work focuses on interdisciplinary approaches to solving complex problems and contributing to the scientific community.
00:00 Introduction
01:01 What Is NMOSD
01:40 Pediatric and Adult Similarities
03:17 No Approved Medications for Children
05:20 Aquaporin-4 and the Immune System
08:25 How Inebilizumab Works
10:54 The Four-Child Case Series
15:42 Results and Tolerability
16:52 Why Inebilizumab Matters
18:25 What This Means for Families and Clinicians
20:13 Ongoing Pediatric Trials and Thanks 2026 RNDS | Pediatric Case Series in Anti-Aquaporin-4 Antibody-Positive NMOSD](https://i.ytimg.com/vi/JuoCbOXEPLw/mqdefault.jpg)




![2026 RNDS | Q-Cell Study Updates
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Benjamin Greenberg, MD, MHS, of the University of Texas Southwestern gave an update on the Q-Cell stem cell study in myelitis [00:00:06]. He explained how stem cells could repair myelin in the spinal cord, along with the risks that took years of animal studies to address, including cells forming something unwanted and the body rejecting them [00:00:59]. He warned about unregulated stem cell clinics and described why Q-Cells were chosen and how a floating cannula delivers them into the spinal cord [00:06:44]. Dr. Greenberg reviewed who can take part, the safety findings so far in the people who have had the procedure, and how to sign up through the SRNA website [00:15:37]. He ended with thanks to donors, the surgical team, and participants, then took audience questions about next steps, including enrolling people with recurrences and treating the neck [00:21:17].
Benjamin Greenberg, MD, MHS, received his Bachelor of Arts degree from Johns Hopkins University and his Masters degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health. He attended medical school at Baylor College of Medicine, completed his neurology residency at The Johns Hopkins Hospital, and joined the Hopkins faculty in neuroimmunology, where he became Co-Director of the Transverse Myelitis Center and Director of the Encephalitis Center. In 2009, he was recruited to the University of Texas Southwestern Medical Center as Director of the new Transverse Myelitis and Neuromyelitis Optica Program, and that same year he established the Pediatric Demyelinating Disease Program at Childrens Medical Center Dallas.
He now serves as Director of the Perot Foundation Neurosciences Translational Research Center within the ODonnell Brain Institute and Vice Chair of Translational Research for the Department of Neurology. Dr. Greenberg is recognized internationally as an expert in rare autoimmune disorders of the central nervous system.
00:00 Welcome and Introduction
00:39 Disclosures
00:59 The Promise of Stem Cells
03:27 Risks of Stem Cell Transplants
06:44 Unregulated Stem Cell Clinics
08:43 Why Q-Cells Were Chosen
11:22 Getting Cells to the Spinal Cord
15:37 Who Can Take Part
18:16 Safety Results So Far
19:51 How to Sign Up and Next Steps
21:17 Acknowledgements
23:17 Questions from the Audience 2026 RNDS | Q-Cell Study Updates](https://i.ytimg.com/vi/MIjzBjwwpoc/mqdefault.jpg)
![2026 RNDS | Spasticity Management and Mobility
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Philippines Cabahug, MD, of the Kennedy Krieger Institute, spoke about spasticity management and mobility [00:01:09]. She defined spasticity as involuntary muscle tightness or spasms that increase when a muscle is stretched quickly, showed clonus and spasms, and explained that when disease affects the brain and spinal cord the reflex arc loses its normal control [00:02:17]. Dr. Cabahug described how spasticity affects pain, movement, hygiene, and sleep, and why a change from a persons usual baseline can act as an early warning sign, with common triggers including bladder, bowel, skin, clothing, and temperature [00:06:27]. She reviewed the steps of management, from addressing triggers and daily slow stretching to standing, splints, physical and occupational therapy, aquatic therapy, medications, Botox injections, an intrathecal baclofen pump, and surgery [00:11:51]. She closed with an action plan and guidance for women of childbearing age on baclofen [00:17:07].
Philippines Cabahug, MD, earned her B.S. in physical therapy at the University of the Philippines in 1994 and her medical degree at St. Lukes-WHQ Memorial, Philippines, in 2000. She completed a physical medicine and rehabilitation (PM&R) residency at the Philippine General Hospital in 2005, a second PM&R residency at Johns Hopkins Hospital in 2012, and a fellowship in spinal cord injury (SCI) medicine at Johns Hopkins Hospital and the Kennedy Krieger Institute in 2013. She practices at the International Center for Spinal Cord Injury at the Kennedy Krieger Institute, where she is director of Musculoskeletal Ultrasound and runs a musculoskeletal diagnostic clinic and an ultrasound-guided intrathecal pump access clinic. She is board certified in PM&R and in spinal cord injury medicine and is a faculty clinical instructor with the Department of Physical Medicine and Rehabilitation at the Johns Hopkins School of Medicine.
00:00 Introduction to Dr. Cabahug
01:09 Welcome and Session Goals
02:17 What Spasticity Is
03:03 Clonus, Reflexes, and Spasms
04:15 Who Is Affected
05:15 Why Spasticity Happens
06:27 Effects on Daily Life
08:30 Triggers to Check For
10:07 Evaluation and Treatment Goals
11:51 Management Options
13:07 Stretching and Therapy at Home
15:43 Medications and Referral
17:07 Action Plan and Care Points 2026 RNDS | Spasticity Management and Mobility](https://i.ytimg.com/vi/MJjT_7wkIZc/mqdefault.jpg)

![1203. Community Spotlight | Rick Telander
The “Community Spotlight” edition of the “Ask the Expert” podcast series shares the stories of our community members. For this episode, Rick Telander joined Dr. GG deFiebre of SRNA to talk about his journey with transverse myelitis (TM). Rick shared about his diagnostic process [00:08:05], the testing that took place, and the treatment and rehabilitation that he received [00:09:25]. He emphasized the importance of early diagnosis, research for better treatments, and support from organizations like SRNA [00:25:02]. Rick also discussed ongoing symptoms, his experience of living with TM, and the childrens book of poetry that he published [00:26:11].
Rick Telander is the Senior Sports Columnist for the Chicago Sun-Times. He is the author of ten books and was previously a senior writer for Sports Illustrated and ESPN, the Magazine. An original member of “The Sportswriters on TV” television show, Rick has been named Illinois Sportswriter of the Year nine times, and his work has been collected in over a dozen anthologies. He has been awarded the Sigma Delta Chi Award by the Society of Professional Journalists and the Dan Jenkins Lifetime Medal for Excellence in Sportswriting from the University of Texas. In 2021 he was inducted into the National Sportswriters Hall of Fame in Winston-Salem, North Carolina. Rick’s book, Sweet Dreams: Poems and Paintings for the Child Abed is available online:
https://www.skyhorsepublishing.com/9781510778337/sweet-dreams/ 1203. Community Spotlight | Rick Telander](https://i.ytimg.com/vi/NFk_-PyV5Hk/mqdefault.jpg)